Abstract

Women with both dense breasts and breast implants present a special challenge for consideration due to the increased incidence of false-positives and false-negatives with mammography [1]. Molecular Breast Imaging [MBI] has provided limited proven benefit until recently, when improvements in camera calibration, enhancement and quantification [2,3], resulted in the ability to differentiate tissue based upon measurable changes in regional blood flow and metabolism [4].

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call